Pfizer (PFE) revenue was $62.6B in FY2025 (-2% YoY). The tables below show the complete quarterly and annual revenue history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Revenue
Fiscal Year
Revenue
YoY
2025
$62.6B
-2%
2024
$63.6B
+7%
2023
$59.6B
-41%
2022
$101.2B
+24%
2021
$81.3B
+95%
2020
$41.7B
+2%
2019
$40.9B
+0%
2018
$40.8B
-22%
2017
$52.5B
-1%
2016
$52.8B
+8%
2015
$48.9B
-2%
2014
$49.6B
-4%
2013
$51.6B
-7%
2012
$55.7B
-10%
2011
$62.0B
-4%
2010
$64.6B
+31%
2009
$49.3B
+2%
2008
$48.3B
-0%
2007
$48.4B
Recent Quarterly Revenue
Quarter
Revenue
Q2 2026
$15.0B
Q1 2026
$14.5B
Q4 2025
$17.6B
Q3 2025
$16.7B
Q2 2025
$14.7B
Q1 2025
$13.7B
Q4 2024
$17.8B
Q3 2024
$17.7B
Q2 2024
$13.3B
Q1 2024
$14.9B
Q4 2023
$14.6B
Q3 2023
$13.5B
Source: PFE on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.